Photocatalytic degradation of diclofenac using TiO2-CdS heterojunction catalysts under visible light irradiation

The present study reports the photocatalytic degradation of analgesic drug diclofenac using the hydrothermally prepared TiO2-CdS heterojunction catalyst. The results suggest that the prepared catalysts exhibited excellent photocatalytic activity under visible light irradiation. The photodegradation kinetics were well fitted to the pseudo-first-order reaction. The apparent reaction rate constant for TC5 catalyst in the diclofenac degradation was 0.02316 min(-1). Mineralisation of diclofenac using TC5 photocatalyst was around 86% within 4 h of irradiation time. The operating parameters such as optimal catalyst dosage, apparent solution pH and the effect of initial diclofenac concentration were also studied using the TC5 catalyst. The role of active species in the degradation mechanism was elucidated and it was found that the hydroxyl radical is the main active species in the diclofenac degradation mechanism. The charge transfer between heterojunction catalysts is facilitated by direct Z-scheme heterojunction structure. The coupled photocatalysts also showed good photochemical stability and reusability over five successive reaction cycles. The tentative degradation pathway has been devised based on LC-MS peaks, and it is found that only m/z 224, m/z 178 and m/z 124 were persisted at the end of the reaction.

Automated summary

This study successfully reported the photocatalytic degradation of diclofenac using hydrothermally prepared TiO2-CdS heterojunction catalyst, with excellent photocatalytic activity and mineralization rate of 86%. The main active species was identified as the hydroxyl radical, facilitated by a direct Z-scheme heterojunction structure, showing good photochemical stability and reusability.